Arcadia Biosciences (NASDAQ:RKDA) Stock Passes Below 50 Day Moving Average – Here’s Why

Posted by Andrew Walz on May 31st, 2026

Arcadia Biosciences, Inc. (NASDAQ:RKDA – Get Free Report) passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $1.20 and traded as low as $0.8731. Arcadia Biosciences shares last traded at $0.9649, with a volume of 134,997 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings downgraded Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, May 21st. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has an average rating of “Sell”.

Check Out Our Latest Stock Analysis on Arcadia Biosciences

Arcadia Biosciences Trading Up 0.8%

The company has a 50-day simple moving average of $1.20 and a 200 day simple moving average of $2.12. The company has a market cap of $1.99 million, a P/E ratio of -0.17 and a beta of 0.52.

Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last announced its quarterly earnings data on Thursday, May 14th. The basic materials company reported ($2.11) EPS for the quarter, missing the consensus estimate of ($0.80) by ($1.31). The business had revenue of $1.10 million during the quarter, compared to the consensus estimate of $1.60 million. Arcadia Biosciences had a negative net margin of 195.94% and a negative return on equity of 113.73%.

About Arcadia Biosciences

(Get Free Report)

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.